Assessment of the risk of developing liver fibrosis in patients with non-alcoholic fatty liver disease

Author:

Arapkhanova M.1,Grinevich V.2,Kravchuk Iu.2,Klitsenko O.3,Seliverstov P.2

Affiliation:

1. City Clinical Polyclinic Thirty-Eight, Saint Petersburg

2. S.M. Kirov Military Medical Academy, Saint Petersburg

3. North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg

Abstract

The prognosis of a patient with non-alcoholic fatty liver disease (NAFLD) is directly related to the development and progression of fibrosis, which is associated with a wide comorbidity. Despite the existence of various options for assessing the risk of liver fibrosis, further development of prognostic systems that reflect the pathological mechanisms of the disease is necessary. Objective. Determination of indicators associated with the pathogenesis of the disease, which, in combination, will identify the risks of progression of fibrosis in patients with NAFLD to optimize the diagnosis of the disease. Materials and methods. An open observational case-control study was conducted in 79 patients with NAFLD, 21 of them without fibrosis (NAFLD without LF), 58 with fibrosis of varying severity (NAFLD with LF). The examination program included general clinical, laboratory, instrumental (including liver elastometry, FibroScan), histological (assessment of liver biopsy specimens), microbiological (gas chromatography–mass spectrometry of microbial markers (GC-MSM)) studies. Results. Using the logistic regression module, a model was built to assess the risk of LF in NAFLD, consisting of 4 indicators: taurocholic acid; glucose; triglycerides; total sum of microbial markers in GC-MSM. The variables included in the model reflect the mutual influence of the most important pathological factors of NAFLD and comorbid pathology. The resulting model has high sensitivity (98.28%), specificity (95.24%) and diagnostic accuracy (97.47%). For the convenience of practical application, a simplified version of the risk assessment model for LF in NAFLD was proposed depending on the number of altered risk factors. Conclusions. A model for assessing the risk of developing LF in patients with NAFLD was built, which included indicators associated with the pathogenesis of the disease. A simplified version of the model has been developed depending on the number of risk factors, the indicators of which are in the unfavorable zone.

Publisher

Russian Vrach, Publishing House Ltd.

Reference27 articles.

1. Лазебник Л.Б., Голованова Е.В., Туркина С.В. и др. Неалкогольная жировая болезнь печени у взрослых: клиника, диагностика, лечение. Рекомендации для терапевтов, третья версия. Экспериментальная и клиническая гастроэнтерология. 2021; 185 (1): 4–52 [Lazebnik L.B., Golovanova E.V., Turkina S.V. et al. Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version. Experimental and Clinical Gastroenterology. 2021; 185 (1): 4–52 (in Russ.)]. DOI: 10.31146/1682-8658-ecg-185-1-4-52

2. Rinella M.E., Neuschwander-Tetri B.A., Siddiqui M.S. et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023; 77 (5): 1797–835. DOI: 10.1097/HEP.0000000000000323

3. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016; 64 (6): 1388–402. DOI: 10.1016/j.jhep.2015.11.004

4. Toh E.M.S., Joseph Ravi P.R., Ming C. et al. Risk of Liver Fibrosis Is Associated with More Severe Strokes, Increased Complications with Thrombolysis, and Mortality. J Clin Med. 2023; 12: 356. DOI: 10.3390/jcm12010356

5. Choi S.W., Kweon S.S., Lee Y.H. et al. Association of liver fibrosis biomarkers with overall and CVD mortality in the Korean population: The Dong-gu study. PLoS One. 2022; 17 (12): e0277729. DOI: 10.1371/journal.pone.0277729

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3